Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis (vol 47, pg 1697, 2013)

被引：0
|
作者：
Venci, J. V.
Gandhi, M. A.
机构：
来源：
ANNALS OF PHARMACOTHERAPY | 2014年 / 48卷 / 05期
关键词：
D O I：
10.1177/1060028014529923
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [11] Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate
    Nicholas, Jacqueline Ann
    Boster, Aaron Lee
    Imitola, Jaime
    O'Connell, Colleen
    Racke, Michael Karl
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 897 - 908
  • [12] A new oral Agent for the Therapy of multiple Sclerosis
    Borchers, Anja
    NERVENHEILKUNDE, 2011, 30 (12) : 1019 - 1019
  • [13] Oral treatment of dimethyl fumarate stimulates remyelination in a progressive mouse model of multiple sclerosis
    Carlson, Noel
    Haerter, Natalie
    Schmidt, Linda
    Wood, Blair
    Soldan, M. Mateo Paz
    Rose, John
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 829 - 829
  • [14] Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis
    da Silva, Gisela Bevilacqua Rolfsen Ferreira
    das Neves, Sofia Pereira
    Oliveira, Susana Cristina Roque
    Marques, Fernanda
    de Oliveira, Anselmo Gomes
    Leite, Fabio de Lima
    Cerqueira, Joao Jose
    JOURNAL OF AUTOIMMUNITY, 2022, 132
  • [15] Natalizumab and multiple sclerosis (vol 71, pg 135, 2013)
    Pimentel, M. L., V
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (06) : I - I
  • [16] PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy (vol 368, pg 1658, 2013)
    van Oosten, Bob W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (20): : 1950 - 1950
  • [17] Therapeutic effects of oral dimethyl fumarate in the Theiler's murine encephalomyelitis virus model of multiple sclerosis
    Carlson, N. G.
    Schmidt, L. A.
    Wood, B.
    Clendennen, C.
    Weber, L. M.
    Soldan, M. Paz
    Rose, J. W.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 163 - 163
  • [18] Dalfampridine: a new agent for symptomatic management of multiple sclerosis (vol 68, pg 2335, 2011)
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (07) : 544 - 544
  • [19] Teriflunomide for the Treatment of Multiple Sclerosis (vol 33, pg 53, 2013)
    Oh, Jiwon
    O'Connor, Paul W.
    SEMINARS IN NEUROLOGY, 2013, 33 (03) : 307 - 307
  • [20] Progressive multifocal leukoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate (vol 8, 2022)
    Lyons, J.
    Hughes, R.
    McCarthy, K.
    Everage, N.
    Kapadia, S.
    Miller, C.
    Singhal, P.
    Smirnakis, K.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (01)
12345